Viewing StudyNCT00422591



Ignite Creation Date: 2024-05-05 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00422591
Status: COMPLETED
Last Update Posted: 2018-08-23
First Post: 2007-01-16

Brief Title: Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia AML
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
AML
Leukemia
Acute Myeloid Leukemia
Keywords:
Name View
Idarubicin View
Cytarabine Idarubicin View
Leukemia View
Acute Myeloid Leukemia View
AML View
Cytarabine View